Grant: Research Tools and Instruments - Category 1 (<$150,000)
University of Western Ontario
$15,000.00
Measuring changes in nuclear receptor binding during fetal and neonatal development using chromatin immunoprecipitation (ChIP)
FY 2008-09
Summary
The inverse relationship between birth weight and post partum health is one of the most fascinating discoveries in mammalian fetal biology. The principal hypothesis governing this relationship, termed 'fetal programming', is that genetic and/or epigenetic changes underlie alterations in fetal development. Understanding the overall role of nuclear receptors in mediating these developmental events would provide us with a better understanding of the mechanisms controlling fetal development. To date, many published studies have been focused upon the effect of maternal insults (i.e. malnutrition and hypoxemia) on specific target genes and physiological parameters in the fetus and neonate. Although this approach is informative, it fails to address by design the more global role of transcription factors (e.g. nuclear receptors) and epigenetic modifications involved underlying the 'reprogramming' of the fetal genome. Collectively, the equipment requested in this proposal will address this deficiency by facilitating the use chromatin immunoprecitation (ChIP) in tissues to examine the alterations in vivo binding of nuclear receptors to the promoters of their respective target genes. Specifically, with the purchase of an S-4000 Sonicator, and an 8-sample Nanodrop Spectrophotometer, we will have the ability to isolate and measure chromatin changes, respectively, during fetal development. With this unique model, we can examine for the first time the developmental changes in the in vivo interactions of nuclear receptors and epigenetic markers to target promoters, which play an important role in the coordinated control of gene transcription during normal and abnormal fetal development.
Program
Research Tools and Instruments - Category 1 (<$150,000)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
374935-2009
Name nom
Hardy, Daniel
Department département
Obstetrics and Gynecology
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2009
Award amount
15000
Program id
EQPEQ
Program nane en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
Measuring changes in nuclear receptor binding during fetal and neonatal development using chromatin immunoprecipitation (ChIP)
Keyword
NA
Application summary
The inverse relationship between birth weight and post partum health is one of the most fascinating discoveries in mammalian fetal biology. The principal hypothesis governing this relationship, termed 'fetal programming', is that genetic and/or epigenetic changes underlie alterations in fetal development. Understanding the overall role of nuclear receptors in mediating these developmental events would provide us with a better understanding of the mechanisms controlling fetal development. To date, many published studies have been focused upon the effect of maternal insults (i.e. malnutrition and hypoxemia) on specific target genes and physiological parameters in the fetus and neonate. Although this approach is informative, it fails to address by design the more global role of transcription factors (e.g. nuclear receptors) and epigenetic modifications involved underlying the 'reprogramming' of the fetal genome. Collectively, the equipment requested in this proposal will address this deficiency by facilitating the use chromatin immunoprecitation (ChIP) in tissues to examine the alterations in vivo binding of nuclear receptors to the promoters of their respective target genes. Specifically, with the purchase of an S-4000 Sonicator, and an 8-sample Nanodrop Spectrophotometer, we will have the ability to isolate and measure chromatin changes, respectively, during fetal development. With this unique model, we can examine for the first time the developmental changes in the in vivo interactions of nuclear receptors and epigenetic markers to target promoters, which play an important role in the coordinated control of gene transcription during normal and abnormal fetal development.